Report Detail

Request for Sample of this report

Chemical & Material Global Lurasidone Hydrochloride API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4638779
    • |
  • 24 October, 2025
    • |
  • Global
    • |
  • 134 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Lurasidone Hydrochloride API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Lurasidone hydrochloride is a hydrochloride obtained by reaction of lurasidone with one equivalent of hydrochloric acid. An atypical antipsychotic agent used for the treatment of schizophrenia. It has a role as a dopaminergic antagonist, a serotonergic antagonist, an adrenergic antagonist and a second generation antipsychotic. It contains a lurasidone.
This report is a detailed and comprehensive analysis for global Lurasidone Hydrochloride API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Lurasidone Hydrochloride API market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Lurasidone Hydrochloride API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Lurasidone Hydrochloride API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Lurasidone Hydrochloride API market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lurasidone Hydrochloride API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lurasidone Hydrochloride API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Piramal Enterprises Limited, Dr. Reddy's Laboratories, ZCL Chemicals Limited, Recipharm AB, Metrochem API Private Limited, Solara Active Pharma Sciences, Johnson Matthey PLC, Teva Pharmaceutical Industries Ltd., Hisun Pharmaceutical Nantong, Sun Pharmaceutical Industries Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Lurasidone Hydrochloride API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥98%
Purity<98%
Market segment by Application
Lurasidone Hydrochloride Tablets
Others
Major players covered
Piramal Enterprises Limited
Dr. Reddy's Laboratories
ZCL Chemicals Limited
Recipharm AB
Metrochem API Private Limited
Solara Active Pharma Sciences
Johnson Matthey PLC
Teva Pharmaceutical Industries Ltd.
Hisun Pharmaceutical Nantong
Sun Pharmaceutical Industries Ltd.
Procos S.p.A.
Neuland Laboratories
Unichem Laboratories Limited
Glenmark Pharmaceuticals
ALP Pharm
Lupin Ltd
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lurasidone Hydrochloride API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lurasidone Hydrochloride API, with price, sales quantity, revenue, and global market share of Lurasidone Hydrochloride API from 2020 to 2025.
Chapter 3, the Lurasidone Hydrochloride API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lurasidone Hydrochloride API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Lurasidone Hydrochloride API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lurasidone Hydrochloride API.
Chapter 14 and 15, to describe Lurasidone Hydrochloride API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Lurasidone Hydrochloride API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Purity≥98%
    • 1.3.3 Purity<98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Lurasidone Hydrochloride API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Lurasidone Hydrochloride Tablets
    • 1.4.3 Others
  • 1.5 Global Lurasidone Hydrochloride API Market Size & Forecast
    • 1.5.1 Global Lurasidone Hydrochloride API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Lurasidone Hydrochloride API Sales Quantity (2020-2031)
    • 1.5.3 Global Lurasidone Hydrochloride API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Piramal Enterprises Limited
    • 2.1.1 Piramal Enterprises Limited Details
    • 2.1.2 Piramal Enterprises Limited Major Business
    • 2.1.3 Piramal Enterprises Limited Lurasidone Hydrochloride API Product and Services
    • 2.1.4 Piramal Enterprises Limited Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Piramal Enterprises Limited Recent Developments/Updates
  • 2.2 Dr. Reddy's Laboratories
    • 2.2.1 Dr. Reddy's Laboratories Details
    • 2.2.2 Dr. Reddy's Laboratories Major Business
    • 2.2.3 Dr. Reddy's Laboratories Lurasidone Hydrochloride API Product and Services
    • 2.2.4 Dr. Reddy's Laboratories Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Dr. Reddy's Laboratories Recent Developments/Updates
  • 2.3 ZCL Chemicals Limited
    • 2.3.1 ZCL Chemicals Limited Details
    • 2.3.2 ZCL Chemicals Limited Major Business
    • 2.3.3 ZCL Chemicals Limited Lurasidone Hydrochloride API Product and Services
    • 2.3.4 ZCL Chemicals Limited Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 ZCL Chemicals Limited Recent Developments/Updates
  • 2.4 Recipharm AB
    • 2.4.1 Recipharm AB Details
    • 2.4.2 Recipharm AB Major Business
    • 2.4.3 Recipharm AB Lurasidone Hydrochloride API Product and Services
    • 2.4.4 Recipharm AB Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Recipharm AB Recent Developments/Updates
  • 2.5 Metrochem API Private Limited
    • 2.5.1 Metrochem API Private Limited Details
    • 2.5.2 Metrochem API Private Limited Major Business
    • 2.5.3 Metrochem API Private Limited Lurasidone Hydrochloride API Product and Services
    • 2.5.4 Metrochem API Private Limited Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Metrochem API Private Limited Recent Developments/Updates
  • 2.6 Solara Active Pharma Sciences
    • 2.6.1 Solara Active Pharma Sciences Details
    • 2.6.2 Solara Active Pharma Sciences Major Business
    • 2.6.3 Solara Active Pharma Sciences Lurasidone Hydrochloride API Product and Services
    • 2.6.4 Solara Active Pharma Sciences Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Solara Active Pharma Sciences Recent Developments/Updates
  • 2.7 Johnson Matthey PLC
    • 2.7.1 Johnson Matthey PLC Details
    • 2.7.2 Johnson Matthey PLC Major Business
    • 2.7.3 Johnson Matthey PLC Lurasidone Hydrochloride API Product and Services
    • 2.7.4 Johnson Matthey PLC Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Johnson Matthey PLC Recent Developments/Updates
  • 2.8 Teva Pharmaceutical Industries Ltd.
    • 2.8.1 Teva Pharmaceutical Industries Ltd. Details
    • 2.8.2 Teva Pharmaceutical Industries Ltd. Major Business
    • 2.8.3 Teva Pharmaceutical Industries Ltd. Lurasidone Hydrochloride API Product and Services
    • 2.8.4 Teva Pharmaceutical Industries Ltd. Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
  • 2.9 Hisun Pharmaceutical Nantong
    • 2.9.1 Hisun Pharmaceutical Nantong Details
    • 2.9.2 Hisun Pharmaceutical Nantong Major Business
    • 2.9.3 Hisun Pharmaceutical Nantong Lurasidone Hydrochloride API Product and Services
    • 2.9.4 Hisun Pharmaceutical Nantong Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Hisun Pharmaceutical Nantong Recent Developments/Updates
  • 2.10 Sun Pharmaceutical Industries Ltd.
    • 2.10.1 Sun Pharmaceutical Industries Ltd. Details
    • 2.10.2 Sun Pharmaceutical Industries Ltd. Major Business
    • 2.10.3 Sun Pharmaceutical Industries Ltd. Lurasidone Hydrochloride API Product and Services
    • 2.10.4 Sun Pharmaceutical Industries Ltd. Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
  • 2.11 Procos S.p.A.
    • 2.11.1 Procos S.p.A. Details
    • 2.11.2 Procos S.p.A. Major Business
    • 2.11.3 Procos S.p.A. Lurasidone Hydrochloride API Product and Services
    • 2.11.4 Procos S.p.A. Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Procos S.p.A. Recent Developments/Updates
  • 2.12 Neuland Laboratories
    • 2.12.1 Neuland Laboratories Details
    • 2.12.2 Neuland Laboratories Major Business
    • 2.12.3 Neuland Laboratories Lurasidone Hydrochloride API Product and Services
    • 2.12.4 Neuland Laboratories Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Neuland Laboratories Recent Developments/Updates
  • 2.13 Unichem Laboratories Limited
    • 2.13.1 Unichem Laboratories Limited Details
    • 2.13.2 Unichem Laboratories Limited Major Business
    • 2.13.3 Unichem Laboratories Limited Lurasidone Hydrochloride API Product and Services
    • 2.13.4 Unichem Laboratories Limited Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Unichem Laboratories Limited Recent Developments/Updates
  • 2.14 Glenmark Pharmaceuticals
    • 2.14.1 Glenmark Pharmaceuticals Details
    • 2.14.2 Glenmark Pharmaceuticals Major Business
    • 2.14.3 Glenmark Pharmaceuticals Lurasidone Hydrochloride API Product and Services
    • 2.14.4 Glenmark Pharmaceuticals Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Glenmark Pharmaceuticals Recent Developments/Updates
  • 2.15 ALP Pharm
    • 2.15.1 ALP Pharm Details
    • 2.15.2 ALP Pharm Major Business
    • 2.15.3 ALP Pharm Lurasidone Hydrochloride API Product and Services
    • 2.15.4 ALP Pharm Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 ALP Pharm Recent Developments/Updates
  • 2.16 Lupin Ltd
    • 2.16.1 Lupin Ltd Details
    • 2.16.2 Lupin Ltd Major Business
    • 2.16.3 Lupin Ltd Lurasidone Hydrochloride API Product and Services
    • 2.16.4 Lupin Ltd Lurasidone Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Lupin Ltd Recent Developments/Updates

3 Competitive Environment: Lurasidone Hydrochloride API by Manufacturer

  • 3.1 Global Lurasidone Hydrochloride API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Lurasidone Hydrochloride API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Lurasidone Hydrochloride API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Lurasidone Hydrochloride API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Lurasidone Hydrochloride API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Lurasidone Hydrochloride API Manufacturer Market Share in 2024
  • 3.5 Lurasidone Hydrochloride API Market: Overall Company Footprint Analysis
    • 3.5.1 Lurasidone Hydrochloride API Market: Region Footprint
    • 3.5.2 Lurasidone Hydrochloride API Market: Company Product Type Footprint
    • 3.5.3 Lurasidone Hydrochloride API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Lurasidone Hydrochloride API Market Size by Region
    • 4.1.1 Global Lurasidone Hydrochloride API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Lurasidone Hydrochloride API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Lurasidone Hydrochloride API Average Price by Region (2020-2031)
  • 4.2 North America Lurasidone Hydrochloride API Consumption Value (2020-2031)
  • 4.3 Europe Lurasidone Hydrochloride API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Lurasidone Hydrochloride API Consumption Value (2020-2031)
  • 4.5 South America Lurasidone Hydrochloride API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Lurasidone Hydrochloride API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Lurasidone Hydrochloride API Sales Quantity by Type (2020-2031)
  • 5.2 Global Lurasidone Hydrochloride API Consumption Value by Type (2020-2031)
  • 5.3 Global Lurasidone Hydrochloride API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Lurasidone Hydrochloride API Sales Quantity by Application (2020-2031)
  • 6.2 Global Lurasidone Hydrochloride API Consumption Value by Application (2020-2031)
  • 6.3 Global Lurasidone Hydrochloride API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Lurasidone Hydrochloride API Sales Quantity by Type (2020-2031)
  • 7.2 North America Lurasidone Hydrochloride API Sales Quantity by Application (2020-2031)
  • 7.3 North America Lurasidone Hydrochloride API Market Size by Country
    • 7.3.1 North America Lurasidone Hydrochloride API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Lurasidone Hydrochloride API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Lurasidone Hydrochloride API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Lurasidone Hydrochloride API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Lurasidone Hydrochloride API Market Size by Country
    • 8.3.1 Europe Lurasidone Hydrochloride API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Lurasidone Hydrochloride API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Lurasidone Hydrochloride API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Lurasidone Hydrochloride API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Lurasidone Hydrochloride API Market Size by Region
    • 9.3.1 Asia-Pacific Lurasidone Hydrochloride API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Lurasidone Hydrochloride API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Lurasidone Hydrochloride API Sales Quantity by Type (2020-2031)
  • 10.2 South America Lurasidone Hydrochloride API Sales Quantity by Application (2020-2031)
  • 10.3 South America Lurasidone Hydrochloride API Market Size by Country
    • 10.3.1 South America Lurasidone Hydrochloride API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Lurasidone Hydrochloride API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Lurasidone Hydrochloride API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Lurasidone Hydrochloride API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Lurasidone Hydrochloride API Market Size by Country
    • 11.3.1 Middle East & Africa Lurasidone Hydrochloride API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Lurasidone Hydrochloride API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Lurasidone Hydrochloride API Market Drivers
  • 12.2 Lurasidone Hydrochloride API Market Restraints
  • 12.3 Lurasidone Hydrochloride API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Lurasidone Hydrochloride API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Lurasidone Hydrochloride API
  • 13.3 Lurasidone Hydrochloride API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Lurasidone Hydrochloride API Typical Distributors
  • 14.3 Lurasidone Hydrochloride API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Lurasidone Hydrochloride API. Industry analysis & Market Report on Lurasidone Hydrochloride API is a syndicated market report, published as Global Lurasidone Hydrochloride API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Lurasidone Hydrochloride API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo